TOURIST 2: Tracking Of Urgent Risks In Swiss Travelers
TOURIST2
An Observational Study Using a Smartphone-app Supported Electronic Survey and Localization Tracking to Map Risk Behaviors and Symptoms of Swiss Travelers to Thailand, China, India, Brazil, Peru and Tanzania From 2 Swiss Travel Clinics
1 other identifier
observational
793
1 country
2
Brief Summary
New mobile Health (mHealth) technology creates an opportunity to approach travel medicine research in a different way, revolutionising our understanding of risks to travellers. Using mHealth technology, the Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich (UZH), developed a TRAVEL app in collaboration with the Eidgnössische Technische Hochschule (ETH) Zurich. By using this new technology, an extensive collection of data (prospective collection of individual travel behaviour and experienced health events, mapping the travel itinerary via global positioning system (GPS), linking to publicly available local weather data and data on disease endemicity) can be combined and an unprecedented abundance of information on travel behaviour and experienced risks can be obtained. These data will allow a much better understanding of travel risk profiles using cluster analysis. By simultaneously recording health outcomes, the relationship between travel risk profiles and health events can be assessed. In this study, the investigators will address several major shortcomings in travel health in tropical and subtropical destinations by improving the understanding of poorly assessed and potentially underestimated health threats (e.g. risk of accidents and injury, mental health disorders), and travel risks specific to elderly travellers and travellers with chronic conditions. These findings will directly feed back into individual travel advice given by practitioners in Switzerland and finally world-wide.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2017
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 16, 2017
CompletedFirst Posted
Study publicly available on registry
August 25, 2017
CompletedStudy Start
First participant enrolled
September 18, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2021
CompletedApril 29, 2021
October 1, 2017
1.5 years
August 16, 2017
April 27, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Self-reported risk behaviors
The study participant will report on daily risk behaviors prior to, during and after travel in a daily app-based questionnaire
for a maximum of 4 weeks during travel
Secondary Outcomes (1)
Self-reported symptoms
for a maximum of 4 weeks during travel
Study Arms (3)
Elderly Travelers
approximately 135 travelers with an age \>= 60 years will be enrolled
Chronic diseased travelers
approximately 225 travelers with a chronic disease will be enrolled
Healthy travelers
approximately 640 healthy travelers with be enrolled
Interventions
none, this is an observational study
Eligibility Criteria
Study recruitment will be conducted at the University of Zurich Travel Clinic and the Travel Clinic at the Swiss Tropical and Public Health Institute. That means that individuals seeking pre-travel advice at one of the two Travel Clinics will be asked to participate based inclusion criteria defined above. Furthermore, patients with chronic diseases will be referred to the Travel Clinics by various specialized clinics at the University Hospitals of Zurich and Basel (Gastroenterology, Rheumatology, Pneumology, Cardiology)
You may qualify if:
- Informed Consent
- Traveler to Thailand, China, India, Brazil, Peru or Tanzania
- German-speaking (level 3 or higher)
- Literate (able to read and write in German - level 3 or higher)
- Capable of operating Smartphone application for data collection
- Traveling to Thailand, China, India, Brazil, Peru or Tanzania for ≤ 4 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Zurichlead
- Swiss Tropical & Public Health Institutecollaborator
Study Sites (2)
Andreas Neumayr
Basel, Canton of Basel-City, 4051, Switzerland
University of Zurich, Epidemiology, Biostatistics and Prevention Institute, Travel Clinic
Zurich, 8001, Switzerland
Related Publications (1)
Farnham A, Blanke U, Stone E, Puhan MA, Hatz C. Travel medicine and mHealth technology: a study using smartphones to collect health data during travel. J Travel Med. 2016 Sep 4;23(6):taw056. doi: 10.1093/jtm/taw056. Print 2016 Jun.
PMID: 27592821BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Silja Bühler, Dr.
University of Zurich
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 16, 2017
First Posted
August 25, 2017
Study Start
September 18, 2017
Primary Completion
March 31, 2019
Study Completion
March 31, 2021
Last Updated
April 29, 2021
Record last verified: 2017-10
Data Sharing
- IPD Sharing
- Will not share